BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Fibrosis
1
Advances in the treatment of nonalcoholic steatohepatitis
10/29/2020 5:34:30 AM | Browse: 2 | Download: 0
2
Periportal thickening on magnetic resonance imaging for hepatic fibrosis in infantile cholestasis
6/6/2020 2:43:56 PM | Browse: 105 | Download: 117
3
Macrophages in metabolic associated fatty liver disease
4/28/2020 8:04:30 AM | Browse: 107 | Download: 100
4
Fibroblast growth factor signaling in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Paving the way to hepatocellular carcinoma
1/16/2020 7:58:40 AM | Browse: 148 | Download: 225
5
Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C
1/13/2020 11:27:12 AM | Browse: 163 | Download: 216
6
Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source
9/7/2019 4:43:36 AM | Browse: 215 | Download: 306
7
Layered enhancement at magnetic resonance enterography in inflammatory bowel disease: A meta-analysis
8/21/2019 9:19:18 AM | Browse: 219 | Download: 318
8
Role of sodium-glucose co-transporter-2 inhibitors in the management of nonalcoholic fatty liver disease
7/28/2019 10:51:57 AM | Browse: 213 | Download: 121
9
Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets
7/6/2019 6:23:58 AM | Browse: 229 | Download: 293
10
Roles of hepatic stellate cells in acute liver failure: From the perspective of inflammation and fibrosis
5/27/2019 8:24:36 AM | Browse: 218 | Download: 240
11
Effectiveness of venous thromboembolism prophylaxis in patients with liver disease
4/26/2019 3:40:00 AM | Browse: 249 | Download: 183
12
Repurposing drugs to target nonalcoholic steatohepatitis
4/18/2019 5:48:09 AM | Browse: 311 | Download: 225
13
Persistent elevation of fibrosis biomarker cartilage oligomeric matrix protein following hepatitis C virus eradication
3/27/2019 10:37:20 AM | Browse: 296 | Download: 258
14
Diffusion-weighted magnetic resonance imaging and micro-RNA in the diagnosis of hepatic fibrosis in chronic hepatitis C virus
3/20/2019 5:32:10 AM | Browse: 358 | Download: 351
15
Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice
3/20/2019 5:32:10 AM | Browse: 305 | Download: 226
16
Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects
2/26/2019 11:29:04 AM | Browse: 353 | Download: 254
17
Human immunodeficiency virus and hepatotropic viruses co-morbidities as the inducers of liver injury progression
1/26/2019 11:40:14 AM | Browse: 355 | Download: 274
18
Correlation analysis of collagen proportionate area in Budd-Chiari syndrome: A preliminary clinicopathological study
1/26/2019 8:24:19 AM | Browse: 232 | Download: 206
19
Current status, problems, and perspectives of non-alcoholic fatty liver disease research
1/14/2019 2:54:12 PM | Browse: 431 | Download: 296
20
Role of cenicriviroc in the management of nonalcoholic fatty liver disease
12/27/2018 8:56:32 AM | Browse: 251 | Download: 166
21
Management of local recurrence after endoscopic resection of neoplastic colonic polyps
12/21/2018 6:09:14 AM | Browse: 302 | Download: 325
22
Liver as a target of human immunodeficiency virus infection
11/13/2018 8:04:45 AM | Browse: 382 | Download: 295
23
Carcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancer
10/18/2018 10:13:24 AM | Browse: 297 | Download: 289
24
A small molecule fibrokinase inhibitor in a model of fibropolycystic hepatorenal disease
9/7/2018 9:21:44 AM | Browse: 361 | Download: 339
25
Polycystic kidney and hepatic disease 1 gene mutations in von Meyenburg complexes: Case report
9/7/2018 1:56:18 AM | Browse: 271 | Download: 187
26
Liver intravoxel incoherent motion diffusion-weighted imaging for the assessment of hepatic steatosis and fibrosis in children
7/19/2018 7:04:34 AM | Browse: 410 | Download: 359
27
Responsibility of hepatitis C virus in the development of hepatocellular carcinoma: From molecular alterations to possible solutions
6/28/2018 2:47:35 AM | Browse: 471 | Download: 310
28
Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction
4/27/2018 3:25:40 AM | Browse: 460 | Download: 238
29
Beneficial effects of naringenin in liver diseases: Molecular mechanisms
4/27/2018 3:25:40 AM | Browse: 467 | Download: 321
30
Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity
4/19/2018 7:56:07 AM | Browse: 429 | Download: 290
31
Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals
3/16/2018 12:27:25 PM | Browse: 480 | Download: 312
32
Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease
3/16/2018 12:27:25 PM | Browse: 423 | Download: 233
33
Collagen proportionate area correlates to hepatic venous pressure gradient in non-abstinent cirrhotic patients with alcoholic liver disease
1/26/2018 8:09:36 AM | Browse: 441 | Download: 262
34
Role of inflammatory response in liver diseases: Therapeutic strategies
1/26/2018 8:09:36 AM | Browse: 553 | Download: 386
35
Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis
1/14/2018 5:07:58 AM | Browse: 562 | Download: 257
36
Antifibrogenic effects of vitamin D derivatives on mouse pancreatic stellate cells
1/14/2018 5:07:58 AM | Browse: 422 | Download: 245
37
Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infection
12/27/2017 10:31:19 AM | Browse: 484 | Download: 351
38
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease
12/20/2017 2:49:19 AM | Browse: 494 | Download: 325
39
Pathological process of liver sinusoidal endothelial cells in liver diseases
11/20/2017 4:03:35 AM | Browse: 551 | Download: 255
40
Risk of liver disease in methotrexate treated patients
9/15/2017 5:43:48 AM | Browse: 502 | Download: 363
41
Expression of matrix metalloproteinase-11 is increased under conditions of insulin resistance
9/13/2017 7:36:12 AM | Browse: 450 | Download: 429
42
CD4+ T cells and natural killer cells: Biomarkers for hepatic fibrosis in human immunodeficiency virus/hepatitis C virus-coinfected patients
9/7/2017 2:39:18 AM | Browse: 449 | Download: 515
43
Fibrinogen deficiency suppresses the development of early and delayed radiation enteropathy
7/12/2017 6:45:23 AM | Browse: 441 | Download: 442
44
Impact of hepatitis C oral therapy in portal hypertension
7/12/2017 6:45:23 AM | Browse: 500 | Download: 741
45
Naringenin prevents experimental liver fibrosis by blocking TGFβ-Smad3 and JNK-Smad3 pathways
6/26/2017 10:23:06 AM | Browse: 470 | Download: 484
46
Cardiac damage in athlete’s heart: When the “supernormal” heart fails!
6/26/2017 12:49:43 AM | Browse: 454 | Download: 295
47
Anti-steatotic and anti-fibrotic effects of the KCa3.1 channel inhibitor, Senicapoc, in non-alcoholic liver disease
6/20/2017 12:12:52 PM | Browse: 494 | Download: 701
48
Serelaxin increases the antifibrotic action of rosiglitazone in a model of hepatic fibrosis
6/14/2017 9:25:57 AM | Browse: 473 | Download: 440
49
Embrionary way to create a fatty liver in portal hypertension
5/16/2017 6:56:36 AM | Browse: 622 | Download: 704
50
Non-invasive evaluation of intestinal disorders: The role of elastographic techniques
4/28/2017 10:26:16 AM | Browse: 462 | Download: 546